Today: 9 June 2026
Circle (CRCL) stock price slips in premarket after 35% surge on USDC-driven earnings beat
26 February 2026
2 mins read

Circle (CRCL) stock price slips in premarket after 35% surge on USDC-driven earnings beat

New York, Feb 26, 2026, 05:06 EST — Premarket

  • Circle shares dipped roughly 0.4% in premarket trading, giving back some ground after their 35.5% surge in the previous session.
  • Quarterly revenue surged for the stablecoin issuer, with USDC in circulation also on the rise.
  • After Wednesday’s surge in volume, investors are eyeing the rate environment and whether buyers will keep stepping in.

Circle Internet Group slipped 0.4% to $82.81 in premarket trading Thursday, following a sharp 35.47% surge that took the stablecoin company’s stock to $83.14 at Wednesday’s close. More than 63 million shares changed hands during that session, according to .

This is significant: Circle stands out as one of the rare U.S.-listed plays that mirrors stablecoin adoption. Dollar-linked crypto tokens, designed to keep their value stable, are showing up more and more in payments and settlements, beyond just trading.

The move throws fresh attention on Washington’s efforts to regulate stablecoins, right as banks and payments companies experiment with using them for transfers beyond standard banking hours.

Circle reported a 77% jump in fourth-quarter total revenue and reserve income, reaching $770 million. Net income from continuing operations landed at $133 million for the period. Adjusted EBITDA came in at $167 million, with the company sticking to its long-term goal of 40% compound annual growth for USDC in circulation. “The fourth quarter marked another step forward in Circle’s mission,” CEO Jeremy Allaire said in the earnings release. SEC

Reserve income remains the key story here—Circle pulls in interest by parking USDC’s backing cash in short-term U.S. Treasuries and deposits. USDC in circulation jumped 72% year-over-year to hit $75.3 billion for the quarter, Reuters said, pushing reserve revenue up to $733 million and letting Circle beat the Street’s revenue estimates. “USDC continues scaling rapidly,” noted Seaport Research Partners analyst Jeff Cantwell. As for rates, CEO Jeremy Allaire told Reuters he’d “welcome” cuts, pointing out that “high rates… slow down the velocity of money.” Reuters

Circle keeps urging investors to look past rates. The company highlighted moves on Arc, its blockchain push, and noted that as of Feb. 20, Circle Payments Network counted 55 financial institutions onboard, with another 74 still in eligibility review.

Allaire pushed back on the idea that stablecoin rails are just a sideshow in prediction markets, calling them a feature. “People want to be able to move quickly,” he said, responding to a question about platforms like Polymarket, per a Benzinga report from the earnings call. Benzinga

Circle’s USDC stands as the second-biggest stablecoin globally by market value, trailing only Tether’s USDT. The company faces tough competition, with an increasing number of dollar-backed tokens entering the space.

Still, the stock’s post-earnings bounce is riding on a single factor: USDC growth needs to keep up, even if interest rates come down. Should circulation slow, or if yields slip more quickly than stablecoin balances increase, reserve income could tighten. That would turn the “rates trade” in the stock against those holding it.

Circle’s updates aside, attention shifts to Friday’s 8:30 a.m. ET release of U.S. producer price figures—a fresh batch of inflation signals that could steer expectations for interest rates.

Coming up, the Federal Reserve’s policy meeting on March 17-18 stands out, with a rate decision and a press conference set for March 18.

Stock Market Today

  • National Stock Exchange of India to Allocate 10% of CSR Funds to NSE Social Stock Exchange Projects
    June 9, 2026, 10:09 AM EDT. The National Stock Exchange of India (NSE) will earmark 10% of its annual Corporate Social Responsibility (CSR) corpus for deployment through projects listed on the NSE Social Stock Exchange (SSE). This move aims to channel corporate funds into social enterprises and initiatives that meet NSE SSE criteria, enhancing transparency and impact measurement. The NSE Social Stock Exchange, launched as a platform to support social ventures, allows investors and corporations to fund causes aligned with social development goals. This allocation underscores NSE's commitment to social responsibility and innovative financing for social impact projects.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Microsoft stock price rebounds as Japan raids Azure unit; MSFT investors eye Nvidia earnings
Previous Story

Microsoft stock price rebounds as Japan raids Azure unit; MSFT investors eye Nvidia earnings

Healthcare Triangle (HCTI) stock jumps 66% premarket on Malaysia TNG eWallet mental-health deal
Next Story

Healthcare Triangle (HCTI) stock jumps 66% premarket on Malaysia TNG eWallet mental-health deal

Go toTop